MAXIDROL, eye drops bottle, 3 ml
Active ingredients: Dexamethasone, Neomycin sulfate, Polymyxin b1 sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Eye dropsbottle, 3 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MAXIDROL, collyre
- Pharmaceutical form
- collyre
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène de 3 ml
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1967
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61605665CIP73065253CIP133400930652534Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DEXAMÉTHASONEcollyre | 100 mg · 100 ml | SA |
| POLYMYXINE B (SULFATE DE)collyre | 600 000 UI · 100 ml | SA |
| NÉOMYCINE (SULFATE DE)collyre | 350 000 UI · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.